| PERIOD ENDING | 31-Dec-09 | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | | Total Revenue | 553,638 | 485,676 | 504,910 | 505,444 | | Cost of Revenue | 262,226 | 240,156 | 249,840 | 254,308 | | | Gross Profit | 291,412 | 245,520 | 255,070 | 251,136 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 170,644 | 153,648 | 159,106 | 164,344 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 120,768 | 91,872 | 95,964 | 86,792 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1) | 105 | 3,168 | (356) | | Earnings Before Interest And Taxes | 120,767 | 91,977 | 99,132 | 86,436 | | Interest Expense | 16,836 | 14,437 | 13,762 | 13,509 | | Income Before Tax | 103,931 | 77,540 | 85,370 | 72,927 | | Income Tax Expense | 32,007 | 21,130 | 25,782 | 21,368 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 71,521 | 56,410 | 59,588 | 51,559 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 71,924 | 56,410 | 59,588 | 51,559 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $71,924 | $56,410 | $59,588 | $51,559 |
|
0.35% Nasdaq 
Income Statement
